Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02375373 · ClinicalTrials.gov registry record

Effects of Adding Chickpeas to the American Diet (Long Term Study)

A clinical trial of Inflammation, sponsored by University of Florida.

Completed
Registry status
12
Enrollment target
1
Study location

NCT02375373: Completed study of Inflammation, sponsored by University of Florida.

NCT02375373 is a study of Inflammation that has completed, run by University of Florida. The registered enrollment target is 12 participants, below the 288-participant average among 132 other Inflammation trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02375373, a study of Inflammation, has completed, sponsored by University of Florida.

COMPLETED
Registry status
12 participants
Enrollment target
1
Study location

Study Summary

This prospective study will assess the effects of adding legumes, especially chick peas, to the diet of healthy adults on the commensal bacteria from feces of human subjects and resulting self-reported GI symptoms as well as markers of immune function.

Primary Outcome

Compare the gut microbiota composition of individual subjects before and after the implementation of a controlled and observed diet of chickpeas and legume products.

Conditions Studied

Interventions

  • OTHER Observational Chickpea Diet

Study Locations (1)

Florida

  • Emerging Pathogens Institiute - Gainesville

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2015-04
Est. Completion 2015-12
University of Florida

1,106 total trials

What the finished NCT02375373 record still lists

NCT02375373 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 288-participant average among 132 other Inflammation trials with a reported enrollment target (96% lower).

The record links to 1 condition, with Inflammation appearing as the primary indexed condition, and to 1 intervention - of which Observational Chickpea Diet is the first listed.

NCT02375373 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT02375373 about?

NCT02375373 is a clinical study titled "Effects of Adding Chickpeas to the American Diet (Long Term Study)". This prospective study will assess the effects of adding legumes, especially chick peas, to the diet of healthy adults on the commensal bacteria from feces of human subjects and resulting self-reported GI symptoms as well as markers of immune function.

What is the current status of trial NCT02375373?

This trial is currently completed. The enrollment target is 12 participants. The study started on 2015-04. Estimated completion is 2015-12.

What conditions does trial NCT02375373 study?

This clinical trial studies the following conditions: Inflammation.

What interventions are being tested in trial NCT02375373?

The interventions under investigation include: Observational Chickpea Diet (OTHER).

Who is sponsoring clinical trial NCT02375373?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02375373 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Inflammation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02375373's enrollment target sits among peer trials

12 125th of 132 higher than 6 of 132 other Inflammation trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Inflammation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02602769 · 12 participants

    Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome

  • NCT02605421 · 12 participants · Phase 2

    Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma

  • NCT02619448 · 12 participants · Early Phase 1

    Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC

  • NCT03311503 · 12 participants · Phase 1

    Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02375373, the US trial registry maintained by the National Library of Medicine. NCT02375373 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.